About this trial
This phase II RCT evaluates the efficacy of a telehealth-delivered extended reality (XR) exergaming intervention on physical activity, cardiometabolic health, and physical fitness in physically inactive children with cerebral palsy (ages 10 to 17). A total of 130 participants will be randomized to either a 12-week XR exergaming intervention with behavioral coaching or a non-intervention control group, followed by a 24-week sustainability phase. Aim 1 examines immediate and sustained effects on physical activity levels. Aim 2 tests effects on cardiometabolic health indicators including blood lipids, blood pressure, and glycemic markers. Aim 3 explores effects on physical fitness and perceived health. All procedures are conducted remotely via telehealth.
Eligibility criteria
Qualifiers
medical diagnosis of cerebral palsy
between the ages of 10-17 years (10 years of age is the minimum requirement of the Meta Quest 3s headset, as noted by the manufacturer)
physician clearance to participate in moderate-intensity exercise
access to a Wi-Fi Internet connection in the home
Disqualifiers
physically active (defined as ≥150 minutes per week of moderate-to-vigorous intensity exercise in a typical week)
prone to photosensitive seizures
a classification of GMFCS level V, which we have found to preclude the ability to use the Oculus Quest hand-held controllers
complete blindness or deafness
Trial design
Treatments tested in this trial
- Extended Reality Exergaming